Charles River Laboratories stock falls on weak 2025 revenue outlook
WILMINGTON, Mass. -- Shares of Charles River Laboratories (NYSE: CRL) fell 5% as the company projected a decline in organic revenue for 2025 similar to the decrease estimated for...